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Tumor necrosis factor-a in response to endotoxin 
administration in the pregnant guinea pig
Ilse Beckmann, MSc, PhD,“ Felicja Meisel-Mikolajczyk, MD, PhD,b Fred K. Lotgering, MD, PhD,“ 
and Henk C.S. Wallenburg, MD, PhD“
Rotterdam, The Netherlands, and Warsaw, Poland
OBJECTIVE: Our purpose was to test the hypothesis that an intramuscular endotoxin challenge induces 
production of tumor necrosis factor-a in the pregnant guinea pig and to investigate some of the 
metabolic effects.
STUDY DESIGN: Twelve randomly selected guinea pigs at 33 days’ gestation with a sampling catheter in 
the carotid artery received an intramuscular injection of a solution of endotoxin isolated from Bacteroides 
fragilis {n = 6) or of solvent alone (n -  6). Plasma values of tumor necrosis factor-a, hematocrit, and 
6-keto-prostaglandin F1a were determined before and several hours after injection.
RESULTS: Tumor necrosis factor-a was detected in five of six guinea pigs, but it could not be 
demonstrated in five of six placebo animals. The hematocrit was significantly decreased, and 
prostaglandin F1a significantly increased 24 to 48 hours after endotoxin injection.
CONCLUSION: In pregnant guinea pigs an intramuscular endotoxin challenge induces the release of 
tumor necrosis factor-a, followed by a reduced hematocrit and an increased prostacyclin concentration. 
These effects could be involved in the pathogenesis of endotoxin-induced fetal growth retardation. (Am J 
Obstet Gynecol 1996;175:218-21.)
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In previous studies we showed in the, p regnant guinea 
pig that repeated  adm inistration of Bacteroides fragilis en­
dotoxin causes fetal growth retardation associated with 
fetal hypoglycemia, fetal and' m aternal hypertriglyceride­
mia, and a m arked increase in  m aternal plasma prostacy­
clin (PGI2) concentrations.1, 2 Similar biochemical 
changes have been reported  to be induced by tum or 
necrosis factor-a (TNF-a) in animal experim ents and in 
man. This po ten t and m ultifunctional cytokine, first d e ­
scribed as a product o f activated macrophages,3 was 
shown to be produced by many types of cells in  female 
reproductive organs and tissues.4 It has a wide range of 
effects on cellular functions and interferes with carbohy­
d rate— and fat metabolism5 and deoxyribonucleic acid— 
synthesis,6 induces anem ia,7 and enhances prostaglandin 
synthesis.8 O ur observations led us to speculate that 
TNF-a could be involved in the pathophysiologic mecha-
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nisms triggered by bacterial endotoxin leading to fetal 
growth retardation.
The curren t study was designed to test the hypothesis 
that adm inistration of B. fragilis endotoxin to the preg­
nan t guinea pig induces form ation of TNF-a associated 
with changes in the metabolism of PGI2, as previously 
observed in endotoxin-induced fetal growth retardation.
Material and methods
Experim ents were perform ed in 12 random ly selected 
albino Dunkin-Hartley guinea pigs at 30 day’s gestation. 
T he first day of gestation was defined as the second day 
of the opening of the vaginal m em brane. The animals 
were kept in  individual cages in a controlled environm ent 
(19° C, 50% humidity, light-dark cycle 13:11 hours) and 
were fed commercial guinea pig pellets, hay, and water 
ad libitum. Vitamin C was added to the drinking water 
twice weekly. The guidelines for the care and use of 
guinea pigs approved by the Erasmus University animal 
experim ents com mittee were followed.
Experimental protocol. O n day 30 o f gestation a poly­
ethylene catheter was in troduced into a carotid artery 
with the animal under general anesthesia with intram us­
cular ketam ine hydrochloride (15 m g/kg  body weight) 
and xylazine hydrochloride (2 m g/kg). After recovery, as 
judged  by restored weight gain 3 or 4 days after surgery, 
an arterial sample was taken from  all animals for the 
determ ination of anti—B. fragilis antibodies. The animals
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were then randomly divided into two groups of six, a 
placebo group (m edian weight 801 gm [range 695 to 875 
gm]) and  an endotoxin group (m edian weight 814 gm 
[range 636 to 880 gm]). At 0 hours the animals of the 
endotoxin group were given an intram uscular injection 
o f 100 p g /k g  endotoxin dissolved in  100 pi of sterile 
phosphate-buffered saline solution at pH  7.4 and mixed 
with 100 pi o f com plete F reund’s adjuvant. The endo­
toxin was extracted from  B. fragilis IPL E 323 and isolated 
as described previously.2 The placebo group received an 
intram uscular injection of 100 pi o f phosphate-buffered 
saline solution mixed with 100 pi o f com plete F reund’s 
adjuvant. Blood samples (1 ml) for determ ination of 
TNF-a and hem atocrit were taken from  the arterial cath­
eter into heparinized tubes immediately before (sample 
0) and 4, 7, 9, 11, 24, and 48 hours after the start o f the 
experim ent. For the determ ination of prostaglandin Flc( 
(PGF1<X), the stable metabolite o f PGI2, blood samples 
(1.5 ml) were collected at 0, 11, 24, and 48 hours into 
cooled plastic tubes containing 10 pi o f heparin and 25 pi 
o f indom ethacin (0.1% in phosphate buffer, pH  7.4). The 
samples were immediately centrifuged for 10 m inutes at 
1500g and 0° C and the supernatants stored at -80° C 
until analysis. After each sampling of heparinized blood 
without indom ethacin, the rem aining erythrocytes were 
resuspended in  saline solution and re tu rned  to the ani­
mals through the arterial catheter.
Stimulation o f  TNF-a release in human and guinea pig 
whole blood. An additional experim ent was done to com­
pare the time course of release of TNF-a by hum an and 
guinea pig monocytes in  vitro after stimulation with 
B. fragilis and  Escherichia coli lipopolysaccharide. Blood 
samples from  a healthy nonpregnan t female hum an do ­
nor and from  a healthy pregnant guinea pig were col­
lected in commercial vacuum tubes with ethylenedi- 
am inetetraacetic acid (Becton-Dickinson, Rutherford, 
N.J.) and 0.5 ml blood was transferred to 6-well tissue 
culture plates (Costar, Cambridge, Mass.) and diluted 
1:10 with RPMI 1640 culture m edium  25 m m ol/L  
HEPES (N-2-hydroxyethylpiperazine-N-2-ethanesulfonic 
acid) (Seralab, Drawley Down, U nited Kingdom) com­
plem ented with 100 U /m l penicillin, 100 p g /m l strepto­
mycin, 4 m m ol/L  L-glutamine, and 10% fetal calf serum  
(Sebak GmbH, Aidenbach, Germany). The samples were 
stimulated with 25 pi o f phosphate-buffered saline solu­
tion (controls), 10 pi o f lipopolysaccharide E. coliO lll B4 
(Sigma, St. Louis) (1 m g /m l phosphate-buffered saline 
solution, or 25 pi o f lipopolysaccharide B. fragilis 
(1 m g /m l phosphate-buffered saline solution and incu­
bated at 37° C for 48 hours in a humidified, 5% carbon 
dioxide atm osphere. Samples (1 ml) were taken after 0, 6, 
24, and 48 hours o f incubation and centrifuged for 10 
m inutes at 1500g and 4° C, and the supernatants were 
stored at -80° C until analysis.
Analytic procedures. Antibody titers against B. fragilis
endotoxin were determ ined in all 0-samples by means of 
a hem agglutination test on m icrotiter plates, with endo ­
toxin-coated sheep erythrocytes as antigens, as described 
previously.1
TNF-a in plasma and blood culture supernatants was 
assessed by bioassay9 with the TNF-a-sensitive m urine 
fibrosarcoma W E H I164 cell line. The WEHI cell line and 
hum an recom binant TNF-a were provided by Dr. R. Mar- 
quet, Erasmus University, Rotterdam. Cell death was m ea­
sured after 20 hours of incubation at 37° C and 5% 
carbon dioxide by the colorimetric MTT (3-{4,5-dimeth- 
ylthiaziol-2-yl }-2,5-diphenyltetrazoliumbromide, Sigma) 
assay.10 A standard titration curve prepared with hum an 
recom binant TNF-a was used to calculate TNF-a values 
from  m easured cytotoxicity. Neutralization of cytotoxicity 
in supernatants of hum an blood cultures was perform ed 
with a polyclonal rabbit antihum an recom binant TNF-a 
antibody (Genzyme, Cambridge, Mass.). The detection 
limit o f the assay was 6 pg /m l.
H em atocrit values were determ ined by the microcapil­
lary technique. Plasma concentrations of 6-keto-PGFl0t 
were determ ined with a commercial radioimmunoassay 
(E.I. Du Pont de Nemours-NEN Research Products, Bos­
ton) as described previously.2
Statistical analysis. Friedm an’s two-way analysis of vari­
ance and W ilcoxon’s rank-sum and rank-sign tests were 
used, as appropriate, to evaluate the differences between 
the continuous variables within and between groups. A 
value of p  < 0.05 was chosen to represent statistical sig­
nificance.
Results
Before the start of the experiments, on gestational day 
33 or 34, hem agglutination titers against B. fragilis endo­
toxin were <1:10 in all animals.
Bioactive TNF-a was detected in plasma of five of the 
six animals in the endotoxin group 9 hours after endo­
toxin adm inistration, with a significant rise to a mean 
level of 400 p g /m l at 11 hours, followed by a significant 
fall to levels below the detection limit at 48 hours; one 
guinea pig showed weak cytotoxicity at 24 hours only. In 
the placebo group five of six animals did no t have any 
cytotoxicity at all within 48 hours; one animal reacted 
with low cytotoxicity at 11 and 24 hours. The results for all 
animals are presented in Fig. 1, A.
In the endotoxin group hem atocrit values were signifi­
cantly (^<0.03) reduced by 33% and 30% at 24 and 48 
hours, respectively, but no significant changes in hem at­
ocrit values were observed in the placebo group during 
the course of the experim ent (Figure 1 ,5 ).
Levels o f 6-keto-PGF1(x in  the endotoxin-treated guinea 
pigs showed a significant rise after 11 hours, whereas no 
significant changes were observed in the placebo group 
(Fig. 1, C).
The results o f the experim ents with B. fragilis and E. coli
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Fig. 1. Mean (±SEM) values o f TNF-a (A), hem atocrit (B), and 
6-keto-PGFlol (C) in plasma of guinea pigs after intram uscular 
adm inistration of B. fragilis endotoxin or placebo. Solid lines, 
Endotoxin group; dashed lines, placebo group.
endotoxin to stimulate release of TNF-a in  guinea pig 
and hum an monocytes are shown in Fig. 2. Cytotoxicity in 
guinea pig samples followed a course similar to that in 
hum an blood. In hum an samples cytotoxicity was com­
pletely neutralized with anti-TNF-a antibody. Maximum 
secretion of TNF-a after B. fragilis endotoxin stimulation 
was reached in both  cultures after 24 hours whereas E. coli 
lipopolysaccharide stimulated TNF-a release in both cul­
tures, with maximal response after 6 hours. TNF-a peak 
levels in supernatants o f hum an and guinea pig blood cul­
tures stimulated with E. coli lipopolysaccharide were 
higher than those by stimulation with B. fragilis endotoxin.
hours of incubation
Fig. 2. Release o f TNF-a from monocytes in full blood cultures 
after stimulation with lipopolysaccharide E. coli 0111 B4 and 
lipopolysaccharide B. fragilis for 6, 24, and 48 hours. Solid line, 
H um an blood stimulated with lipopolysaccharide E. coli; double 
solid line, hum an blood stimulated with lipopolysaccharide 
B. fragilis; dashed line, guinea pig blood stimulated with li­
popolysaccharide E. coli; dotted line, b lood stimulated with li­
popolysaccharide B. fragilis.
Comment
We chose the sensitive and specific W EHI bioassay for 
analysis o f TNF-a rather than an immunoassay. D epend­
ing on the choice of the antibody, immunoassays detect 
various TNF-a m onom ers and polymers, TNF-a degrada­
tion products, or TN F-a/sTN F-a-receptor complexes, 
which are biologically inactive.11
In plasma of pregnant guinea pigs we detected TNF-a 9 
hours after adm inistration of B. fragilis endotoxin, with 
peak values at 11 hours and a return  to baseline levels 
after >24 hours. No reports of com parable experiments 
could be found in the literature. Zuckerm an and Ben- 
dele12 found that intraperitoneal adm inistration of E. coli 
lipopolysaccharide (2 m g/kg  body weight) in nonpreg­
nan t guinea pigs caused a rapid rise o f serum  TNF-a 
levels, with peak values between <0.2 and 180 n g /m l 
2 hours after injection and a re tu rn  to base level after 
6 hours. The differences in the time course and peak 
values of TNF-a between that study and our experiments 
in pregnant guinea pigs may be explained by the low 
concentration of injected lipopolysaccharide (100 pg /kg  
body weight) in our experim ents and, in particular, by the 
intram uscular adm inistration of the endotoxin, with a 
m uch slower uptake into the m aternal circulation than 
after intraperitoneal or intravenous injection.
Also, the bacterial origin of the endotoxin may influ­
ence the host’s immunologic and pathophysiologic re­
sponse. Most studies involving the release of TNF-a after 
injection of endotoxins in mice used intravenously or in-
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traperitoneally adm inistered lipopolysaccharide from 
gram-negative aerobes, primarily Enterobacteriaceae 
such as E. coli or Salmonella species. In our m odel o f endo­
toxin-induced fetal growth retardation2 in the pregnant 
guinea pig we used the purified lipopolysaccharide of 
!>. fragilis because Bacteroides species are frequently in­
volved in intrauterine infections during pregnancy.13 
There is evidence that the endotoxin of B.fragilisis biologi­
cally less active than are the endotoxins isolated from En­
terobacteriaceae.14 This may also explain the difference in 
peak levels o f TNF-a stimulated by E. coli and B. fragilis 
endotoxin as observed by Zuckerm an and B endele12 and 
in the stimulation experim ents shown in Fig. 2.
T he neutralization of cytotoxicity in hum an blood su­
pernatants by anti hu-re TNF-a antibody identified the 
cytotoxic agent as TNF-a. The lack of an anti-guinea pig 
TNF-a antibody and the low and irreproducible crossre­
activity of antihum an TNF-a antiserum  with guinea pig 
TNF-a precluded the exact identification of the cytotox­
icity in guinea pig plasma. However, the similar time 
course of TNF-a release in hum an and guinea pig blood 
cultures after stimulation with B. fragilis and E. coli li­
popolysaccharide suggests that the released cytotoxic fac­
tor in guinea pig blood was indeed TNF-a. This assump­
tion is supported by the fact that the WEHI cell line used 
in our experim ents to detect cytotoxicity in guinea pig 
plasma is specifically sensitive to TNF-a and insensitive to 
other cytokines such as in terleukin-la , interleukin-1 p, 
interleukin-6, and in terferon gam m a.15 ■
T he observation of reduced hem atocrit values in endo­
toxin-treated guinea pigs 24 to 48 hours after endotoxin 
adm inistration (Fig. 1, B) may be explained by the capac­
ity of endotoxin or TNF-a to induce anem ia in vivo by 
reducing the life span of circulating red  blood cells and 
in terfering with erythropoiesis.7' 16 Microscopic blood loss 
in urine or stool from  TNF-a cytotoxicity17 could be in­
volved, b u t this was n o t determ ined in our experiments.
O ur observation of a significant increase in circulating 
PGFla 11 and 24 hours after endotoxin injection is in 
agreem ent with results o f studies in hum ans in whom 
TNF-a was triggered by endotoxin and was shown to 
cause increased levels of circulating PGI2.8 An increased 
production of PGI2 was also observed after stimulation of 
guinea pig macrophages with endotoxin in vitro.18
In hum an pregnancy elevated levels o f bioactive TNF-a 
in m idtrim ester am niotic fluid were associated with sub­
sequent small-for-gestational-age births and various 
pathophysiologic mechanisms affecting the fetus, pla­
centa, or both, by which this m ultifunctional cytokine 
may m ediate im paired fetal growth have been sug­
gested.19 The results of our experim ental study in the 
pregnant guinea pig support the concept that the release 
of bacterial endotoxin in subclinical infection may in­
duce abnorm al activation of the im m une system with 
release of cytokines, which may n o t only contribute to the 
occurrence of p reterm  labor13 but may also in some cases 
lead to im pairm ent o f fetal growth.
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